Business Collaboration

Across regulated, semi-regulated and non-regulated markets, we deploy best practices and our sincerest efforts to fulfil unmet needs. Through our experience, we’ve learned that international relationships aren’t built on superficial figures and dealings. Instead, they’re built on a deep understanding of the locale, conditions and demands of the region. This is why we endeavour to make our worldwide relationships local and easy to navigate by using our various types of engagements.

Our Models:

CMO (Contract Manufacturing Organization) for regulated markets and CDMO (Contract Development and Manufacturing Organization) – Our contractual collaborations enable us and other partners abroad to widen the pharmaceutical horizon with our distinct products.

New Development – we strive to make leaps and bounds with our partners, and in this case, from scratch.

Dossier Out-Licensing Of New Development Of Products– Our wide range of products is licensed to our partners who are in turn able to serve an underserved market.

Dossier In-Licensing For Novel Product – Our production capacities are scaling quickly and through in-licensing we’re able to adopt new ideas into our wing.

We have a widespread network around the world and our global presence allows us to have a worldwide impact. The more we grow, the more we learn. We’ve found that with our roots laid everywhere and through our fruitful international partnerships, we can truly bolster the medical cause. To do so, we ensure timely, thorough and logistically seamless deliveries. We don’t take our technology or people for granted. Instead, we work to make sure that we evolve constantly. Not unexpectedly then, we meet all safety and registration standards in the countries we serve.

Therefore, at the core of our business collaborations is our zealous desire to grow together, in tandem with our global partners.